Filing Flows › Entera Bio (ENTX) › Q1 2025 › vs Q4 2024
Entera Bio (ENTX) Q1 2025 vs Q4 2024 (quarter over quarter)
Entera Bio's revenue fell $40K (-49%) from $82K in Q4 2024 to $42K in Q1 2025.
Entera Bio, Q1 2025: revenue $42K, net loss $2.6M, operating cash flow −$1.4M. The chart draws each line against Q4 2024, the increases inside each band.
Every line
| Line | Q1 2025 | Q4 2024 | Change | % |
|---|---|---|---|---|
| Revenue | $42K | $82K | −$40K | -49% |
| Net loss | $2.6M | $2.4M | $209K | +9% |
| Costs & expenses | $2.6M | $2.4M | $169K | +7% |
| Operating costs | $2.6M | $2.4M | $186K | +8% |
| Interest & other, net | $4K | $7K | −$3K | -43% |
| Cost of revenue | $42K | $82K | −$40K | -49% |
| Research & development | $1.1M | $1.2M | −$78K | -6% |
| SG&A | $123K | $96K | $27K | +28% |
| Other operating costs | $1.3M | $1.0M | $277K | +27% |
| Operating cash sources | $2.6M | $2.4M | $209K | +9% |
| Depreciation | $8K | $11K | −$3K | -27% |
| Share-based compensation | $604K | $566K | $38K | +7% |
| Working capital & other | $551K | $314K | $237K | +75% |
| Cash used in operations | $1.4M | $1.5M | −$63K | -4% |
| Net loss absorbed | $2.6M | $2.4M | $209K | +9% |
Questions
How much did Entera Bio's revenue grow quarter over quarter in Q1 2025?
Entera Bio's revenue fell $40K (-49%) from $82K in Q4 2024 to $42K in Q1 2025.